NCT03669497: Hypo-Fractionated Radiotherapy in Breast Cancer

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be planning for local radiation therapy
Exclusions: Patients with breast reconstruction using implants; Prior radiation to the chest wall / breast

Comments are closed.

Up ↑